http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102872035-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcc35f152994b9dd00422a05c7e7572f |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
filingDate | 2012-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc570b07d4063c42e09dcaa0f330894c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8568c44c3b643a0044036a2844cd4ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ed7b2f60646f61b214ffebb865618a6 |
publicationDate | 2014-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102872035-B |
titleOfInvention | Application of Gypensapogenin A in medicaments against platelet aggregation |
abstract | The invention relates to an application of Gypensapogenin A in preparing medicaments against platelet aggregation. The application of Gypensapogenin A in preparing medicaments against platelet aggregation, involved in the invention, is disclosed for the first time. As the skeleton is brand new, and the activity of Gypensapogenin A against platelet aggregation is unexpectedly strong, the possibility that any enlightenments are given by other compounds does not exist. Gypensapogenin A has prominent substantive features and has notable progress when being used for preparing medicaments against platelet aggregation. |
priorityDate | 2012-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.